Mrs
Dr
Miss
Ms
Prof
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/2113205
OTC Pharmaceuticals in Australia
Description:
Introduction
OTC Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Australia otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
-The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2010 annual average exchange rates.
-The Australian OTC pharmaceuticals market generated total revenues of $3.5 billion in 2010, representing a compound annual growth rate (CAGR) of 4.9% for the period spanning 2006-2010.
-Traditional medicines sales proved the most lucrative for the Australian OTC pharmaceuticals market in 2010, generating total revenues of $1.4 billion, equivalent to 41.6% of the market's overall value.
-The performance of the market is forecast to decelerate, with an anticipated CAGR of 3.9% for the five-year period 2010-2015, which is expected to lead the market to a value of $4.2 billion by the end of 2015.
Features
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in Australia
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in Australia
Leading company profiles reveal details of key otc pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Australia otc pharmaceuticals market with five year forecasts by both value and volume
Macroeconomic indicators provide insight into general trends within the Australia economy
Key Questions Answered
What was the size of the Australia otc pharmaceuticals market by value in 2010?
What will be the size of the Australia otc pharmaceuticals market in 2015?
What factors are affecting the strength of competition in the Australia otc pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitiors in Australia's otc pharmaceuticals market?
OTC Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Australia otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
-The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2010 annual average exchange rates.
-The Australian OTC pharmaceuticals market generated total revenues of $3.5 billion in 2010, representing a compound annual growth rate (CAGR) of 4.9% for the period spanning 2006-2010.
-Traditional medicines sales proved the most lucrative for the Australian OTC pharmaceuticals market in 2010, generating total revenues of $1.4 billion, equivalent to 41.6% of the market's overall value.
-The performance of the market is forecast to decelerate, with an anticipated CAGR of 3.9% for the five-year period 2010-2015, which is expected to lead the market to a value of $4.2 billion by the end of 2015.
Features
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in Australia
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in Australia
Leading company profiles reveal details of key otc pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Australia otc pharmaceuticals market with five year forecasts by both value and volume
Macroeconomic indicators provide insight into general trends within the Australia economy
Key Questions Answered
What was the size of the Australia otc pharmaceuticals market by value in 2010?
What will be the size of the Australia otc pharmaceuticals market in 2015?
What factors are affecting the strength of competition in the Australia otc pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitiors in Australia's otc pharmaceuticals market?
Contents:
TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 6
Market definition 6
Market analysis 6
MARKET DATA 7
Market value 7
MARKET SEGMENTATION 8
Category segmentation 8
Geography segmentation 10
Market share 11
Market distribution 12
MARKET OUTLOOK 13
Market value forecast 13
FIVE FORCES ANALYSIS 14
Summary 14
Buyer power 15
Supplier power 16
New entrants 17
Threat of substitutes 18
Degree of rivalry 19
LEADING COMPANIES 20
Cerebos Pacific Limited 20
Reckitt Benckiser Group plc 22
Johnson & Johnson 26
MACROECONOMIC INDICATORS 30
Country Data 30
APPENDIX 32
Methodology 32
Industry associations 33
Related MarketLine research 33
LIST OF TABLES
Table 1: Australia OTC pharmaceuticals market value: $ million, 2006–10 7
Table 2: Australia OTC pharmaceuticals market category segmentation : % share, by value, 2006 - 2010 8
Table 3: Australia OTC pharmaceuticals market category segmentation : $million, by value, 2006 - 2010 8
Table 4: Australia OTC pharmaceuticals market geography segmentation, by value, 2010 10
Table 5: Australia OTC pharmaceuticals market share: % share, by value, 2010 11
Table 6: Australia OTC pharmaceuticals market distribution: % share, by value, 2010 12
Table 7: Australia OTC pharmaceuticals market value forecast: $ million, 2010–15 13
Table 8: Cerebos Pacific Limited: key facts 20
Table 9: Reckitt Benckiser Group plc: key facts 22
Table 10: Reckitt Benckiser Group plc: key financials ($) 23
Table 11: Reckitt Benckiser Group plc: key financials (£) 23
Table 12: Reckitt Benckiser Group plc: key financial ratios 24
Table 13: Johnson & Johnson: key facts 26
Table 14: Johnson & Johnson: key financials ($) 27
Table 15: Johnson & Johnson: key financial ratios 28
Table 16: Australia size of population (million), 2006–10 30
Table 17: Australia gdp (constant 2000 prices, $ billion), 2006–10 30
Table 18: Australia gdp (current prices, $ billion), 2006–10 30
Table 19: Australia inflation, 2006–10 31
Table 20: Australia consumer price index (absolute), 2006–10 31
Table 21: Australia exchange rate, 2006–10 31
LIST OF FIGURES
Figure 1: Australia OTC pharmaceuticals market value: $ million, 2006–10 7
Figure 2: Australia OTC pharmaceuticals market category segmentation : $million, by value, 2006 - 2010 9
Figure 3: Australia OTC pharmaceuticals market geography segmentation : % share, by value, 2010 10
Figure 4: Australia OTC pharmaceuticals market share: % share, by value, 2010 11
Figure 5: Australia OTC pharmaceuticals market distribution: % share, by value, 2010 12
Figure 6: Australia OTC pharmaceuticals market value forecast: $ million, 2010–15 13
Figure 7: Forces driving competition in the OTC pharmaceuticals market in Australia, 2010 14
Figure 8: Drivers of buyer power in the OTC pharmaceuticals market in Australia, 2010 15
Figure 9: Drivers of supplier power in the OTC pharmaceuticals market in Australia, 2010 16
Figure 10: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Australia, 2010 17
Figure 11: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Australia, 2010 18
Figure 12: Drivers of degree of rivalry in the OTC pharmaceuticals market in Australia, 2010 19
Figure 13: Reckitt Benckiser Group plc: revenues & profitability 24
Figure 14: Reckitt Benckiser Group plc: assets & liabilities 25
Figure 15: Johnson & Johnson: revenues & profitability 28
Figure 16: Johnson & Johnson: assets & liabilities 29
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 6
Market definition 6
Market analysis 6
MARKET DATA 7
Market value 7
MARKET SEGMENTATION 8
Category segmentation 8
Geography segmentation 10
Market share 11
Market distribution 12
MARKET OUTLOOK 13
Market value forecast 13
FIVE FORCES ANALYSIS 14
Summary 14
Buyer power 15
Supplier power 16
New entrants 17
Threat of substitutes 18
Degree of rivalry 19
LEADING COMPANIES 20
Cerebos Pacific Limited 20
Reckitt Benckiser Group plc 22
Johnson & Johnson 26
MACROECONOMIC INDICATORS 30
Country Data 30
APPENDIX 32
Methodology 32
Industry associations 33
Related MarketLine research 33
LIST OF TABLES
Table 1: Australia OTC pharmaceuticals market value: $ million, 2006–10 7
Table 2: Australia OTC pharmaceuticals market category segmentation : % share, by value, 2006 - 2010 8
Table 3: Australia OTC pharmaceuticals market category segmentation : $million, by value, 2006 - 2010 8
Table 4: Australia OTC pharmaceuticals market geography segmentation, by value, 2010 10
Table 5: Australia OTC pharmaceuticals market share: % share, by value, 2010 11
Table 6: Australia OTC pharmaceuticals market distribution: % share, by value, 2010 12
Table 7: Australia OTC pharmaceuticals market value forecast: $ million, 2010–15 13
Table 8: Cerebos Pacific Limited: key facts 20
Table 9: Reckitt Benckiser Group plc: key facts 22
Table 10: Reckitt Benckiser Group plc: key financials ($) 23
Table 11: Reckitt Benckiser Group plc: key financials (£) 23
Table 12: Reckitt Benckiser Group plc: key financial ratios 24
Table 13: Johnson & Johnson: key facts 26
Table 14: Johnson & Johnson: key financials ($) 27
Table 15: Johnson & Johnson: key financial ratios 28
Table 16: Australia size of population (million), 2006–10 30
Table 17: Australia gdp (constant 2000 prices, $ billion), 2006–10 30
Table 18: Australia gdp (current prices, $ billion), 2006–10 30
Table 19: Australia inflation, 2006–10 31
Table 20: Australia consumer price index (absolute), 2006–10 31
Table 21: Australia exchange rate, 2006–10 31
LIST OF FIGURES
Figure 1: Australia OTC pharmaceuticals market value: $ million, 2006–10 7
Figure 2: Australia OTC pharmaceuticals market category segmentation : $million, by value, 2006 - 2010 9
Figure 3: Australia OTC pharmaceuticals market geography segmentation : % share, by value, 2010 10
Figure 4: Australia OTC pharmaceuticals market share: % share, by value, 2010 11
Figure 5: Australia OTC pharmaceuticals market distribution: % share, by value, 2010 12
Figure 6: Australia OTC pharmaceuticals market value forecast: $ million, 2010–15 13
Figure 7: Forces driving competition in the OTC pharmaceuticals market in Australia, 2010 14
Figure 8: Drivers of buyer power in the OTC pharmaceuticals market in Australia, 2010 15
Figure 9: Drivers of supplier power in the OTC pharmaceuticals market in Australia, 2010 16
Figure 10: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Australia, 2010 17
Figure 11: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Australia, 2010 18
Figure 12: Drivers of degree of rivalry in the OTC pharmaceuticals market in Australia, 2010 19
Figure 13: Reckitt Benckiser Group plc: revenues & profitability 24
Figure 14: Reckitt Benckiser Group plc: assets & liabilities 25
Figure 15: Johnson & Johnson: revenues & profitability 28
Figure 16: Johnson & Johnson: assets & liabilities 29
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/1582661
Order by Fax - using the order form below
Order By Post - print the order form below and send to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Page 1 of 2
Printed Saturday, May 25, 2013
12:21:43 AM
12:21:43 AM
Fax order form
To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
Product name
OTC Pharmaceuticals in Australia
Web Address
http://www.researchandmarkets.com/reports/2113205
Office Code
OC8DIQSMSTPRXS
Report Formats
Please enter the quantity of the report format you require.
| Format | Quantity | Price | Electronic (PDF) - Enterprisewide |
|
EURO€ 673.00 |
|---|---|---|
| Electronic (PDF) - Single User |
|
EURO€ 269.00 |
Contact information
Please enter all the information below in block capitals.
Title:
Mr
Mrs
Dr
Miss
Ms
Prof
Mrs
Dr
Miss
Ms
Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Page 2 of 2
Printed Saturday, May 25, 2013
12:21:43 AM
12:21:43 AM
Payment information
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
Pay by Check:
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Pay by Wire Transfer:
Please transfer funds to:
Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp